BioInnovatse Contract Manufacturing & Development (CDMO) Profile
BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. Our teams advise and produce custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA.
We specialize in molecular biology products and services to advance research in the early discovery phases of cell and gene therapy, immunotherapy, precision medicine, regenerative medicine, stem cell research, and vaccine development.
Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to supporting researchers in their pursuit of making new breakthroughs in their respective fields.
CDMO Services:
Biologics; Cell & Gene Therapy Research & Development
Year Founded: 2009
Head Office: Rockville, United States
Number of Facilities: 1-2
Facility locations: North America
Website: Visit the BioInnovatse website
Linkedin: Connect on Linkedin
Current Capacity: Plasmid DNA and viral vector productions for early discovery applications and volumes ranging from cell cultures to rat models.